/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | IXHLIncannex Healthcare |
|---|---|
| Last close | $2.38close 2026-11-02 |
| Change % | -5.56%close 2026-11-02 |
| Market cap | $30Mclose 2026-11-02 |
| P/E | loss, no P/E |
| Revenue | $0⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax As ofFY ending 2026-06-30 Filing10-K · 0001628280-26-063506 · filed 2026-09-25 Open the filing on EDGAR →Open the XBRL payload →CiteIncannex Healthcare Inc. (IXHL), us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax: 0 USD, fiscal year ended 2026-06-30. Form 10-K, accession 0001628280-26-063506, filed 2026-09-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001873875/us-gaap/RevenueFromContractWithCustomerIncludingAssessedTax.json |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -100.0%FY to 2026-06-30 |
| Net income | $-19302000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-06-30 Filing10-K · 0001628280-26-063506 · filed 2026-09-25 Open the filing on EDGAR →Open the XBRL payload →CiteIncannex Healthcare Inc. (IXHL), us-gaap:NetIncomeLoss: -19,302,000 USD, fiscal year ended 2026-06-30. Form 10-K, accession 0001628280-26-063506, filed 2026-09-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001873875/us-gaap/NetIncomeLoss.json |
| Net margin | zero in the filing |
| EPS (diluted) | $-1.66⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2026-06-30 Filing10-K · 0001628280-26-063506 · filed 2026-09-25 Open the filing on EDGAR →Open the XBRL payload →CiteIncannex Healthcare Inc. (IXHL), us-gaap:EarningsPerShareDiluted: -1.66 USD per share, fiscal year ended 2026-06-30. Form 10-K, accession 0001628280-26-063506, filed 2026-09-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001873875/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | not scored |
| Altman Z-ScoreUNVALIDATED | not scored |
| Beneish M-ScoreUNVALIDATED | not scored |
| Next earnings | — |